HIV vaccine（Progenics）

N/A

Report date: 2022/12/29 15:03:10

Base Information

Drug NameHIV vaccine（Progenics）

Drug Alias NameProVax（Progenics）HIV gp140 vaccine（Progenics）

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProgenics Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesProgenics Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A